Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Inhibrx Biosciences, Inc.”

7 pharma patents match "Inhibrx Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "Inhibrx Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “Inhibrx Biosciences, Inc.” · 30,257 patents in full index Clear search

  1. US 12365728

    DLL3 single domain antibodies and therapeutic compositions thereof

    Inhibrx Biosciences, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  2. US 12331132

    Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses

    Inhibrx Biosciences, Inc. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  3. US 12331126

    OX40-binding polypeptides and uses thereof

    Inhibrx Biosciences, Inc. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  4. US 12227584

    Multivalent and multispecific OX40-binding fusion proteins

    Inhibrx Biosciences, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  5. US 12187804

    Multivalent and multispecific 41BB-binding proteins

    Inhibrx Biosciences, Inc. · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  6. US 12084502

    CD33-binding polypeptides and uses thereof

    Inhibrx Biosciences, Inc. · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  7. US 12043667

    CLEC12a binding polypeptides and uses thereof

    Inhibrx Biosciences, Inc. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted